Probing the Role of Melanocortin Type 1 Receptor Agonists in Diverse Immunological Diseases
Background: The melanocortin α-melanocyte stimulating hormone (α-MSH), an endogenous peptide with high affinity for the melanocortin 1 receptor (MC1r), has demonstrated prevention and reversal of intestinal and ocular inflammation in animal models. Preclinical studies were performed to determine whe...
Main Authors: | Carl Spana, Andrew W. Taylor, David G. Yee, Marie Makhlina, Wei Yang, John Dodd |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2018.01535/full |
Similar Items
-
A novel oral formulation of the melanocortin-1 receptor agonist PL8177 resolves inflammation in preclinical studies of inflammatory bowel disease and is gut restricted in rats, dogs, and humans
by: John Dodd, et al.
Published: (2023-02-01) -
Stimulating the Melanocortin System in Uveitis and Diabetes Preserves the Structure and Anti-Inflammatory Activity of the Retina
by: Tat Fong Ng, et al.
Published: (2023-04-01) -
Melanocortin 1 Receptor: Structure, Function and Regulation
by: Erin Marissa Wolf Horrell, et al.
Published: (2016-05-01) -
Melanocortin systems on pigment dispersion in fish chromatophores
by: Yuki eKobayashi, et al.
Published: (2012-02-01) -
Melanocortin System in Kidney Homeostasis and Disease: Novel Therapeutic Opportunities
by: Mingyang Chang, et al.
Published: (2021-02-01)